Literature DB >> 3024209

Clinically occult breast lesions: localization and significance.

A L Rosenberg, G F Schwartz, S A Feig, A S Patchefsky.   

Abstract

From early 1974 through September 1985, 927 needle-guided breast biopsies were performed for clinically occult breast lesions. Two hundred and seventy (29%) of these lesions were malignant. This frequency of malignancy was comparable to a 20% frequency in biopsy samples obtained because of clinical (palpable) findings. Of 142 patients with nonpalpable invasive lesions who underwent axillary dissection, 42 (30%) had histologically confirmed axillary metastases. Although these invasive lesions may be clinically occult, they are not inconsequential and demand appropriate treatment. For those patients in this series undergoing mastectomy, the frequency of multicentric cancer in the same breast was 39%. The past 10 years have witnessed a trend in surgical management away from the standard radical or modified radical mastectomy toward limited surgery and radiation therapy for so-called early breast cancer. When planning treatment for these occult lesions, one must consider their biological potential to metastasize as well as their propensity for multicentricity.

Entities:  

Mesh:

Year:  1987        PMID: 3024209     DOI: 10.1148/radiology.162.1.3024209

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  8 in total

1.  Optimized approach to decision fusion of heterogeneous data for breast cancer diagnosis.

Authors:  Jonathan L Jesneck; Loren W Nolte; Jay A Baker; Carey E Floyd; Joseph Y Lo
Journal:  Med Phys       Date:  2006-08       Impact factor: 4.071

2.  Breast mass classification on sonographic images on the basis of shape analysis.

Authors:  Hamid Behnam; Fahimeh Sadat Zakeri; Nasrin Ahmadinejad
Journal:  J Med Ultrason (2001)       Date:  2010-08-07       Impact factor: 1.314

3.  Nonpalpable breast lesions: preoperative radiological guidance in radioguided occult lesion localisation (ROLL).

Authors:  E Belloni; C Canevari; P Panizza; A Marassi; M Rodighiero; S Tacchini; V Zuber; I Sassi; L Gianolli; F Fazio; A Del Maschio
Journal:  Radiol Med       Date:  2011-03-07       Impact factor: 3.469

4.  The value of ultrasound-guided tattooing localization of nonpalpable breast lesions.

Authors:  Kyungran Ko; Boo Kyung Han; Kyung Mi Jang; Yeon Hyeon Choe; Jung Hee Shin; Jung Hyun Yang; Suk Jin Nam
Journal:  Korean J Radiol       Date:  2007 Jul-Aug       Impact factor: 3.500

5.  Stereotactic core needle biopsy of mammographic breast lesions as a viable alternative to surgical biopsy.

Authors:  R A Mikhail; R C Nathan; M Weiss; R M Tummala; U R Mullangi; L Lawrence; A Mukkamala
Journal:  Ann Surg Oncol       Date:  1994-09       Impact factor: 5.344

6.  X-ray and ultrasound localization of non-palpable breast lesions and difficulties in management.

Authors:  J J Tate; G T Royle; P McDonald; P B Guyer; I Taylor
Journal:  J R Soc Med       Date:  1987-11       Impact factor: 18.000

7.  Identification of a mimotope for circulating anti-cytokeratin 8/18 antibody and its usage for the diagnosis of breast cancer.

Authors:  Chang-Kyu Heo; Hai-Min Hwang; Ah Ruem; Dae-Yeul Yu; Ju Yeon Lee; Jong Shin Yoo; In Gyu Kim; Hyang Sook Yoo; Sejeong Oh; Jeong Heon Ko; Eun-Wie Cho
Journal:  Int J Oncol       Date:  2012-10-26       Impact factor: 5.650

8.  Do serum biomarkers really measure breast cancer?

Authors:  Jonathan L Jesneck; Sayan Mukherjee; Zoya Yurkovetsky; Merlise Clyde; Jeffrey R Marks; Anna E Lokshin; Joseph Y Lo
Journal:  BMC Cancer       Date:  2009-05-28       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.